AgomAb Therapeutics

0 followers


AgomAb is pioneering therapies that modulate regenerative pathways to achieve structural tissue repair and functional organ recovery.

Industries

Headquarters

Stage

Employees

Links

Org chart

Tim Knotnerus

Collapse
Tolga Hassan
Chief Financial Officer
Philippe Wiesel
Chief Medical Officer
Paolo Michieli
Chief Scientific Officer
Torsten Dreier
Chief Development Officer
Paul van der Horst
Chief Business Officer
Ellen Lefever
General Counsel
Andrea Sáez
Head of Portfolio Management
Andrea Sáez Borderías
Head of Portfolio Management
Henk De Jonghe
ICT-manager
Malene Watzinger
Head of Preclinical Safety
Maria Nichol
Head of IP
Nadia Vancolard
Clinical trial manager
Natalie De Jonge
Regulatory Affairs Manager